INNOVOTEX Expands Macrocycle Drug Conjugate Platform via Dual-Payload Technology for Tumor-Selective Combination Therapy
Provisional patent application is directed to a dual-payload MDC designed to exploit synthetic lethality in a single tumor-localizing construct AUSTIN, TX, UNITED STATES, September 28, 2026 /EINPresswire.com/ -- INNOVOTEX Inc., a privately held, …
Short extract only — this publisher licenses its text. Read the full release at the source.
More from EIN - Australia
- Kiteworks' Decision to Ensure Customer Data Protection Through Customer-Wide Shutdown Navigates Credible Threat
- New Children’s Book SUPERCHARGED! Batty and the Battery Rescue Team Takes Aim at a Growing Battery Fire Problem
- Liquid Noble launches gBuy for automated shopping with gold and silver
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,400+ feeds — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →